Show
Sort by
-
- Journal Article
- A1
- open access
A novel standard for systematic reporting of neuroblastoma surgery : the International Neuroblastoma Surgical Report Form (INSRF), a joint initiative by the Pediatric Oncological Cooperative Groups SIOPEN, COG and GPOH
-
- Journal Article
- A1
- open access
A G316A polymorphism in the ornithine decarboxylase gene promoter modulates MYCN-driven childhood neuroblastoma
-
Accelerating drug development for neuroblastoma : summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma
-
The ornithine decarboxylase G316A promoter polymorphism impacts neuroblastoma clinical outcome and may identify patients particularly susceptible to polyamine inhibition
-
A mechanistic classification of clinical phenotypes in neuroblastoma.
-
- Journal Article
- A1
- open access
Targeting tachykinin receptors in neuroblastoma
-
Accelerating drug development for neuroblastoma - New drug development strategy : an Innovative Therapies for Children with Cancer, European Network for Cancer Research in Children and Adolescents and International Society of Paediatric Oncology Europe Neuroblastoma project
-
Targeting MYCN-driven transcription by BET-bromodomain inhibition
-
- Journal Article
- A1
- open access
MYCN and HDAC5 transcriptionally repress CD9 to trigger invasion and metastasis in neuroblastoma
-
- Journal Article
- A1
- open access
Sensitivity to cdk1-inhibition is modulated by p53 status in preclinical models of embryonal tumors